Altre lingue Aprogen Medicines Inc.

Azioni

A007460

KR7007460009

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 03/05/2024			Variaz. 5gg	Var. 1 gen.
1.488 ^KRW	+0,27%		+0,74%	+55,00%

19/03	Aprogen Medicines Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
2023	Aprogen Medicines Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	11/12
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Aprogen Medicines Inc. announced that it has received KRW 5.5 billion in funding	23/10/23
Aprogen Medicines Inc. announced that it expects to receive KRW 5.5 billion in funding	13/10/23
Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding	14/09/23
Aprogen Medicines Inc. announced that it expects to receive KRW 70 billion in funding	08/09/23
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.	12/04/23
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.	04/10/22
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.	18/07/22
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.	18/11/21
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.	16/09/21
Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	21/01/21
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..	14/01/21
Aprogen KIC Inc. announced that it expects to receive KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	07/01/21
Aprogen KIC Inc. announced that it has received KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	13/10/20
Aprogen KIC Inc. announced that it expects to receive KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	12/10/20

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aprogen Medicines Inc.

Azioni

A007460

KR7007460009

Altre lingue

Filtri